Fatty acid oxidation drives acetyl-CoA-dependent H3K9ac reprogramming to promote adaptive resistance to BRAF&lt;sup&gt;V600E&lt;/sup&gt; inhibition in thyroid cancer. Here, BRAF is linked to thyroid cancer.